Pharmafile Logo
Pharmafocus logo
Advanced Search

Wyeth to open clinical trial ‘Super Centres’

February 23, 2006
Research and Development

Wyeth has unveiled plans to streamline its drug development operations by opening a network of clinical trial 'Super Centres' around …

News

Pfizer’s new blood infection drug Eraxis approved

February 23, 2006
Research and Development

Eraxis, a new treatment for potentially life-threatening fungal infections has been approved in the US.Pfizer's new antifungal is licensed to …

News

Sanofi’s wonder drug in limbo after regulator’s rejection

February 23, 2006
Sales and Marketing

The future of Sanofi-Aventis' Acomplia is in serious doubt after regulators demanded more data for its use in weight loss, …

News

Pegasys recommended as front line hepatitis B treatment

February 23, 2006
Sales and Marketing

Roche's Pegasys is set to be used more widely in England and Wales to treat hepatitis B following the release …

News

Tysabri trials restart after safety scare

February 20, 2006
Research and Development

Clinical trials of Tysabri, the troubled multiple sclerosis treatment, are to begin again in the US after the FDA gave …

News

Avastin trial recruitment suspended after patient deaths

February 16, 2006
Research and Development

Roche has stopped recruiting colon cancer patients who have undergone surgery to a trial of Avastin after four suddenly died.The …

News

WHO calls for action on counterfeits

February 16, 2006
Manufacturing and Production

The World Health Organisation has called for 'immediate concrete' action against counterfeit medicines, which it says pose serious and sometimes …

News

Woman loses Herceptin court case

February 16, 2006

Breast cancer patient Ann Marie Rogers has lost her court battle to be prescribed Herceptin on the NHS, in what …

News

Merck files novel diabetes drug Januvia

February 16, 2006
Sales and Marketing

Merck has filed an innovative new diabetes treatment with the US regulator, and hopes the drug could be one of …

News

Working with NHS priorities

February 16, 2006

Patients, health professionals and even some politicians have said it, now chief medical officer Nigel Crisp has confirmed it in …

Feature

Safety scare spells the end for Exanta

February 15, 2006
Sales and Marketing

AstraZeneca is to abandon its novel anti-blood clotting drug Exanta after concerns emerged about its long-term safety.Just two years ago, …

News

Wyeth joins search for promising TLR drugs

February 15, 2006
Research and Development

A new collaboration between Wyeth and an Irish biotech company is to investigate the potential of 'toll like receptors', which …

News

Reaching new heights in branding

February 15, 2006
Sales and Marketing

The pharma industry has come a long way from the days when it believed that products were all about safety …

Feature

Talman and Crozier launch new PR agency

February 14, 2006
Medical Communications

Two senior healthcare PR executives have launched Just:: a new agency which they say will redefine the traditional client/agency relationship.Emma …

News

Abbott suspended from ABPI over sleaze

February 10, 2006
Sales and Marketing ethics

All expenses paid trips for doctors to see greyhound racing, visits to Wimbledon centre court and even a lap dancing …

News

More Tamiflu released for UK areas hit by seasonal flu

February 10, 2006
Sales and Marketing

Extra supplies of anti-viral treatment Tamiflu are to be made available in areas of the UK suffering from high levels …

News

GSK looks ahead to surge of products in 2006

February 10, 2006
Sales and Marketing

GlaxoSmithKline has unveiled strong growth in sales and earnings in 2005, and is preparing for a series of key filings, …

News

GSK’s research chief leaves for Gates Foundation

February 9, 2006
Research and Development

GlaxoSmithKline's head of research and development Tachi Yamada is to leave the company, having been recruited by Bill Gates to …

News

Doctors warn on new medical assistant proposals

February 9, 2006

 Doctors have warned that patients may be confused by new non-medically trained assistants, who the government want to carry out …

News

Pfizer considers sale of OTC division

February 8, 2006
Sales and Marketing

Pfizer says it is considering selling off its consumer medicines division as part of a new drive to improve flagging …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025